MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: Nanoclinic in the brain

ACS Nano

Volumn 9, Issue 5, 2015, Pages 5594-5608

  Patil, Rameshwar ^a   Ljubimov, Alexander V ^a,c   Gangalum, Pallavi R ^a   Ding, Hui ^a   Portilla Arias, Jose ^a   Wagner, Shawn ^a   Inoue, Satoshi ^a,d   Konda, Bindu ^a   Rekechenetskiy, Arthur ^a   Chesnokova, Alexandra ^a   Markman, Janet L ^a   Ljubimov, Vladimir A ^b   Li, Debiao ^a   Prasad, Ravi S ^a   Black, Keith L ^a,c   Holler, Eggehard ^a,c   Ljubimova, Julia Y ^a,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Arrogene Inc   (United States)

^d Samuel Oschin Comprehensive Cancer Center Cedars Sinai Medical Center ^*  (Japan)

Author keywords

blood brain barrier; brain metastasis; MRI; nanoconjugate; nanomedicine; tumor targeting; tumor treatment

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; BLOOD; BRAIN; DISEASES; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; MOLECULAR IMAGING; NANOCONJUGATES; NONINVASIVE MEDICAL PROCEDURES; PATHOLOGY; STEM CELLS; TUMORS;

BLOOD-BRAIN BARRIER; BRAIN METASTASIS; NANOCONJUGATE; TUMOR TARGETING; TUMOR TREATMENT;

DIAGNOSIS;

ANTISENSE OLIGONUCLEOTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NANOCONJUGATE;

ANIMAL; BIOPSY; BLOOD BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL TRANSFORMATION; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METASTASIS; MOUSE; NANOMEDICINE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROCEDURES; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BIOPSY; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; NANOCONJUGATES; NANOMEDICINE; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS;

EID: 84930613607     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b01872     Document Type: Article

References (54)

1. Steeg, P. S.; Camphausen, K. A.; Smith, Q. R. Brain Metastases as Preventive and Therapeutic Targets Nat. Rev. Cancer 2011, 11, 352-363
2. Khanfir, A.; Lahiani, F.; Bouzguenda, R.; Ayedi, I.; Daoud, J.; Frikha, M. Prognostic Factors and Survival in Metastatic Breast Cancer: A Single Institution Experience Rep. Pract. Oncol. Radiother. 2013, 18, 127-132
3. Ranjan, T.; Abrey, L. E. Current Management of Metastatic Brain Disease Neurotherapeutics 2009, 6, 598-603
4. Lu, J.; Steeg, P. S.; Price, J. E.; Krishnamurthy, S.; Mani, S. A.; Reuben, J.; Cristofanilli, M.; Dontu, G.; Bidaut, L.; Valero, V. et al. Breast Cancer Metastasis: Challenges and Opportunities Cancer Res. 2009, 69, 4951-4953
5. Vona-Davis, L.; Rose, D. P.; Gadiyaram, V.; Ducatman, B.; Hobbs, G.; Hazard, H.; Kurian, S.; Abraham, J. Breast Cancer Pathology, Receptor Status, and Patterns of Metastasis in a Rural Appalachian Population J. Cancer Epidemiol. 2014, 2014, 170634
6. Lin, N. U.; Amiri-Kordestani, L.; Palmieri, D.; Liewehr, D. J.; Steeg, P. S. CNS Metastases in Breast Cancer: Old Challenge, New Frontiers Clin. Cancer Res. 2013, 19, 6404-6418
7. Eldredge, H. B.; Denittis, A.; Duhadaway, J. B.; Chernick, M.; Metz, R.; Prendergast, G. C. Concurrent Whole Brain Radiotherapy and Short-Course Chloroquine in Patients with Brain Metastases: A Pilot Trial J. Radiat. Oncol. 2013, 2, 315-321
8. Nayak, L.; Lee, E. Q.; Wen, P. Y. Epidemiology of Brain Metastases Curr. Oncol. Rep. 2012, 14, 48-54
9. Baselga, J. Targeting Tyrosine Kinases in Cancer: The Second Wave Science 2006, 312, 1175-1178
10. Renfrow, J. J.; Lesser, G. J. Molecular Subtyping of Brain Metastases and Implications for Therapy Curr. Treat. Options Oncol. 2013, 14, 514-527
11. Lin, N. U.; Claus, E.; Sohl, J.; Razzak, A. R.; Arnaout, A.; Winer, E. P. Sites of Distant Recurrence and Clinical Outcomes in Patients with Metastatic Triple-Negative Breast Cancer: High Incidence of Central Nervous System Metastases Cancer 2008, 113, 2638-2645
12. Schouten, L. J.; Rutten, J.; Huveneers, H. A.; Twijnstra, A. Incidence of Brain Metastases in a Cohort of Patients with Carcinoma of the Breast, Colon, Kidney, and Lung and Melanoma Cancer 2002, 94, 2698-2705
13. Brabletz, T.; Lyden, D.; Steeg, P. S.; Werb, Z. Roadblocks to Translational Advances on Metastasis Research Nat. Med. 2013, 19, 1104-1109
14. Gallego Perez-Larraya, J.; Hildebrand, J. Brain Metastases Handb. Clin. Neurol. 2014, 121, 1143-1157
15. Jia, W.; Lu, R.; Martin, T. A.; Jiang, W. G. The Role of Claudin-5 in Blood-Brain Barrier (BBB) and Brain Metastases (Review) Mol. Med. Rep. 2014, 9, 779-785
16. Lin, N. U. Targeted Therapies in Brain Metastases Curr. Treat. Options Neurol. 2014, 16, 276
17. Inoue, S.; Patil, R.; Portilla-Arias, J.; Ding, H.; Konda, B.; Espinoza, A.; Mongayt, D.; Markman, J. L.; Elramsisy, A.; Phillips, H. W. et al. Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer PLoS One 2012, 7, e31070
18. Markman, J. L.; Rekechenetskiy, A.; Holler, E.; Ljubimova, J. Y. Nanomedicine Therapeutic Approaches to Overcome Cancer Drug Resistance Adv. Drug Delivery Rev. 2013, 65, 1866-1879
19. Pardridge, W. M. Blood-Brain Barrier Drug Delivery of IgG Fusion Proteins with a Transferrin Receptor Monoclonal Antibody Expert Opin. Drug Delivery 2015, 12, 207-222
20. Bickel, U.; Yoshikawa, T.; Pardridge, W. M. Delivery of Peptides and Proteins through the Blood-Brain Barrier Adv. Drug Delivery Rev. 2001, 46, 247-279
21. Daniels, T. R.; Bernabeu, E.; Rodriguez, J. A.; Patel, S.; Kozman, M.; Chiappetta, D. A.; Holler, E.; Ljubimova, J. Y.; Helguera, G.; Penichet, M. L. The Transferrin Receptor and the Targeted Delivery of Therapeutic Agents against Cancer Biochim. Biophys. Acta 2012, 1820, 291-317
22. Ljubimova, J. Y.; Portilla-Arias, J.; Patil, R.; Ding, H.; Inoue, S.; Markman, J. L.; Rekechenetskiy, A.; Konda, B.; Gangalum, P. R.; Chesnokova, A. et al. Toxicity and Efficacy Evaluation of Multiple Targeted Polymalic Acid Conjugates for Triple-Negative Breast Cancer Treatment J. Drug Target. 2013, 21, 956-967
23. Lee, B. S.; Fujita, M.; Khazenzon, N. M.; Wawrowsky, K. A.; Wachsmann-Hogiu, S.; Farkas, D. L.; Black, K. L.; Ljubimova, J. Y.; Holler, E. Polycefin, a New Prototype of a Multifunctional Nanoconjugate Based on Poly(β- l -Malic Acid) for Drug Delivery Bioconjugate Chem. 2006, 17, 317-326
24. Inoue, S.; Ding, H.; Portilla-Arias, J.; Hu, J.; Konda, B.; Fujita, M.; Espinoza, A.; Suhane, S.; Riley, M.; Gates, M. et al. Polymalic Acid-Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting Both HER2/Neu Receptor Synthesis and Activity Cancer Res. 2011, 71, 1454-1464
25. Allard, M.; Doucet, D.; Kien, P.; Bonnemain, B.; Caille, J. M. Experimental Study of DOTA-Gadolinium. Pharmacokinetics and Pharmacologic Properties Invest. Radiol. 1988, 23, S271-274
26. Pestalozzi, B. C.; Brignoli, S. Trastuzumab in CSF J. Clin. Oncol. 2000, 18, 2349-2351
27. Sun, M.; Behrens, C.; Feng, L.; Ozburn, N.; Tang, X.; Yin, G.; Komaki, R.; Varella-Garcia, M.; Hong, W. K.; Aldape, K. D. et al. HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors Clin. Cancer Res. 2009, 15, 4829-4837
28. Hu, J.; Ljubimova, J. Y.; Inoue, S.; Konda, B.; Patil, R.; Ding, H.; Espinoza, A.; Wawrowsky, K. A.; Patil, C.; Ljubimov, A. V. et al. Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models PLoS One 2010, 5, e10108
29. Emlet, D. R.; Gupta, P.; Holgado-Madruga, M.; Del Vecchio, C. A.; Mitra, S. S.; Han, S. Y.; Li, G.; Jensen, K. C.; Vogel, H.; Xu, L. W. et al. Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III Cancer Res. 2014, 74, 1238-1249
30. Frese, K. K.; Tuveson, D. A. Maximizing Mouse Cancer Models Nat. Rev. Cancer 2007, 7, 645-658
31. Brugnoli, F.; Grassilli, S.; Piazzi, M.; Palomba, M.; Nika, E.; Bavelloni, A.; Capitani, S.; Bertagnolo, V. In Triple Negative Breast Tumor Cells, PLC-β2 Promotes the Conversion of CD133high to CD133low Phenotype and Reduces the CD133-Related Invasiveness Mol. Cancer 2013, 12, 165
32. Moelling, K.; Schad, K.; Bosse, M.; Zimmermann, S.; Schweneker, M. Regulation of Raf-Akt Cross-Talk J. Biol. Chem. 2002, 277, 31099-31106
33. Chautard, E.; Ouedraogo, Z. G.; Biau, J.; Verrelle, P. Role of Akt in Human Malignant Glioma: From Oncogenesis to Tumor Aggressiveness J. Neurooncol. 2014, 117, 205-215
34. Nadal, R.; Ortega, F. G.; Salido, M.; Lorente, J. A.; Rodríguez-Rivera, M.; Delgado-Rodríguez, M.; Macià, M.; Fernández, A.; Corominas, J. M.; Garcia-Puche, J. L. et al. CD133 Expression in Circulating Tumor Cells from Breast Cancer Patients: Potential Role in Resistance to Chemotherapy Int. J. Cancer 2013, 133, 2398-2407
35. Ding, H.; Inoue, S.; Ljubimov, A. V.; Patil, R.; Portilla-Arias, J.; Hu, J.; Konda, B.; Wawrowsky, K. A.; Fujita, M.; Karabalin, N. et al. Inhibition of Brain Tumor Growth by Intravenous Poly (β- l -Malic Acid) Nanobioconjugate with pH-Dependent Drug Release Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 18143-18148
36. Langer, R.; Weissleder, R. Nanotechnology JAMA 2015, 313, 135-136
37. Choi, B. D.; Kuan, C. T.; Cai, M.; Archer, G. E.; Mitchell, D. A.; Gedeon, P. C.; Sanchez-Perez, L.; Pastan, I.; Bigner, D. D.; Sampson, J. H. Systemic Administration of a Bispecific Antibody Targeting EGFRvIII Successfully Treats Intracerebral Glioma Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 270-275
38. Fitzgerald, D. P.; Subramanian, P.; Deshpande, M.; Graves, C.; Gordon, I.; Qian, Y. Z.; Snitkovsky, Y.; Liewehr, D. J.; Steinberg, S. M.; Paltán-Ortiz, J. D. et al. Opposing Effects of Pigment Epithelium-Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage Cancer Res. 2012, 72, 144-153
39. Kominsky, S. L.; Tyler, B.; Sosnowski, J.; Brady, K.; Doucet, M.; Nell, D.; Smedley, J. G., 3rd; McClane, B.; Brem, H.; Sukumar, S. Clostridium Perfringens Enterotoxin as a Novel-Targeted Therapeutic for Brain Metastasis Cancer Res. 2007, 67, 7977-7982
40. Kong, D. S.; Kim, M. H.; Jeon, J. W.; Kim, S. Y.; Kim, M. S.; Joo, K. M.; Park, K.; Nam, D. H. Antitumor Activity of ZD6474 in a Metastatic Orthotopic Brain Tumor Model Mol. Med. Rep. 2008, 1, 343-346
41. Valiente, M.; Obenauf, A. C.; Jin, X.; Chen, Q.; Zhang, X. H.; Lee, D. J.; Chaft, J. E.; Kris, M. G.; Huse, J. T.; Brogi, E. et al. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis Cell 2014, 156, 1002-1016
42. Fujita, M.; Lee, B. S.; Khazenzon, N. M.; Penichet, M. L.; Wawrowsky, K. A.; Patil, R.; Ding, H.; Holler, E.; Black, K. L.; Ljubimova, J. Y. Brain Tumor Tandem Targeting Using a Combination of Monoclonal Antibodies Attached to Biopoly(β-L-Malic Acid) J. Controlled Release 2007, 122, 356-363
43. Bien-Ly, N.; Yu, Y. J.; Bumbaca, D.; Elstrott, J.; Boswell, C. A.; Zhang, Y.; Luk, W.; Lu, Y.; Dennis, M. S.; Weimer, R. M. et al. Transferrin Receptor (TfR) Trafficking Determines Brain Uptake of TfR Antibody Affinity Variants J. Exp. Med. 2014, 211, 233-244
44. Gaviani, P.; Silvani, A.; Lamperti, E.; Botturi, A.; Simonetti, G.; Ferrari, D.; Salmaggi, A. Neuro-Oncological Diagnosis in Patients without Histological Confirmation Neurol. Sci. 2011, 32 (Suppl 2) S213-215
45. Hatake, K.; Tokudome, N.; Ito, Y. Next Generation Molecular Targeted Agents for Breast Cancer: Focus on EGFR and VEGFR Pathways Breast Cancer 2007, 14, 132-149
46. Peddi, P. F.; Hurvitz, S. A. PI3K Pathway Inhibitors for the Treatment of Brain Metastases with a Focus on HER2+ Breast Cancer J. Neurooncol. 2014, 117, 7-13
47. Nair, R.; Roden, D. L.; Teo, W. S.; McFarland, A.; Junankar, S.; Ye, S.; Nguyen, A.; Yang, J.; Nikolic, I.; Hui, M.; Morey, A. et al. C-Myc and Her2 Cooperate to Drive a Stem-Like Phenotype with Poor Prognosis in Breast Cancer Oncogene 2013, 33, 3992-4002
48. Singh, S.; Chellappan, S. Lung Cancer Stem Cells: Molecular Features and Therapeutic Targets Mol. Aspects Med. 2014, 39, 50-60
49. Rosen, J. M.; Jordan, C. T. The Increasing Complexity of the Cancer Stem Cell Paradigm Science 2009, 324, 1670-1673
50. Fritz, A.; Sinha, S.; Marella, N.; Berezney, R. Alterations in Replication Timing of Cancer-Related Genes in Malignant Human Breast Cancer Cells J. Cell Biochem. 2013, 114, 1074-1083
51. Ljubimova, J. Y.; Ding, H.; Portilla-Arias, J.; Patil, R.; Gangalum, P. R.; Chesnokova, A.; Inoue, S.; Rekechenetskiy, A.; Nassoura, T.; Black, K. L. et al. Polymalic Acid-Based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine? J. Vis. Exp. 2014, 88, e50668
52. Barge, A.; Cravotto, G.; Gianolio, E.; Fedeli, F. How to Determine Free Gd and Free Ligand in Solution of Gd Chelates. A Technical Note Contrast Media Mol. Imaging 2006, 1, 184-188
53. Nag, A.; Mitra, G.; Ghosh, P. C. A Colorimetric Assay for Estimation of Polyethylene Glycol and Polyethylene Glycolated Protein Using Ammonium Ferrothiocyanate Anal. Biochem. 1996, 237, 224-231
54. Carlsson, J.; Drevin, H.; Axen, R. Protein Thiolation and Reversible Protein-Protein Conjugation. N-Succinimidyl 3-(2-Pyridyldithio)Propionate, a New Heterobifunctional Reagent Biochem. J. 1978, 173, 723-737